XaMINA: A Real-World, Prospective, Observational Study of Treatment-Naïve Patients Treated with Rivaroxaban for Stroke Prevention in Atrial Fibrillation in Asia
The XaMINA Investigators
研究成果: Article › 同行評審
The XaMINA Investigators
研究成果: Article › 同行評審